TB Day 2021 - Expert Panel recording
Expert Panel discussion

As part of World TB Day 2021, QIAGEN held an expert panel discussing TB to COVID 19, which is now available to watch.

Dr. Davide Manissero and a panel of global tuberculosis experts discussed TB control and prevention in the time of COVID-19. The lively roundtable discussion covered the challenges faced in the field of tuberculosis today.

Register below to watch the expert panel now.

  • Impact of the COVID-19 pandemic and associated emergency measures on worldwide TB services
    Prof. Andrea Gori, University of Milano-Bicocca and San Gerardo Hospital, Monza, Italy
  • Increase in poverty-related TB risk factors
    Dr. Alawode Oladele, DeKalb County Board of Health in the State of Georgia, USA
  • COVID-19 laboratory-based and point-of-care testing: can we learn from TB?
    Prof. Francis Drobniewski, Imperial College, London, UK
  • Ways forward to minimize the impact of the pandemic and achieve End TB strategy goals
    Prof. Salmaan Keshavjee, Harvard Medical School, Boston, MA, USA
  • LTBI testing: raising awareness
    Dr. Simon Tiberi, Department of Infection at Barts Health NHS Trust, London, UK
  • Dr. Davide Manissero, Chair
    Dr. Manissero is Chief Medical Officer – Infection and Immune Diagnostics, QIAGEN, and Honorary Senior Lecturer in Public Health at the University College of London. His experience spans from diagnostic to drug development, and he has held senior public health positions at the WHO and European CDC.
    Dr. Davide Manissero
  • Dr. Alawode Oladele
    Dr. Oladele is the Medical Consultant of County Wide Services at the DeKalb County Board of Health in the State of Georgia, USA, where he serves as a USCIS Civil Surgeon in addition to providing travel health consultations and directing the medical services in both the refugee health program, and the tuberculosis program.
    Dr. Alawode Oladele
  • Prof. Francis Drobniewski
    Prof. Drobniewski is a clinical and public health microbiologist, physician (accredited in microbiology, virology and immunology) and Professor of Global Health and Tuberculosis at Imperial College, London (ICL). He has 25 years’ experience as PI/Co-I for complex respiratory research programs focusing on TB/HIV and antimicrobial drug resistance (AMR), integrating clinical, biological and social themes.
    Prof. Francis Drobniewski
  • Dr. Simon Tiberi
    Dr. Tiberi is a Consultant Physician in Infectious Diseases and Research Lead for the Department of Infection at Barts Health NHS Trust, London, UK. He runs an Infectious Diseases clinic and ward, and holds an NTM clinic, HIV-TB and MDR-TB clinic. Simon is currently the principal investigator of the RECOVERY trial for Barts Health NHS trust.
    Dr. Simon Tiberi
  • Prof. Andrea Gori
    Prof. Gori is a Professor of Infectious Diseases at the University of Milano-Bicocca, and Director Department of Internal Medicine, Chief Clinic of Infectious Diseases at San Gerardo Hospital in Monza. Since 1992, he has been engaged in both infectious diseases research and clinical care.
    Prof. Andrea Gori
  • Prof. Salmaan Keshavjee
    Prof. Keshavjee is Professor of Global Health and Social Medicine at Harvard Medical School and the Director of Harvard Medical School’s Center for Global Health Delivery. He is also a physician in the Division of Global Health Equity at Boston’s Brigham and Women’s Hospital. Dr. Keshavjee is a leading expert in tuberculosis treatment and the anthropology of health policy.
    Prof. Salmaan Keshavjee
  • Dr. Davide Manissero
    Dr. Davide Manissero, Chair
  • Dr. Alawode Oladele
    Dr. Alawode Oladele
  • Prof. Francis Drobniewski
    Prof. Francis Drobniewski
  • Dr. Simon Tiberi
    Dr. Simon Tiberi
  • Prof. Andrea Gori
    Prof. Andrea Gori
  • Prof. Salmaan Keshavjee
    Prof. Salmaan Keshavjee
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm